Researchers develop innovative STAb therapy for a type of leukemia

GOSH delivers world-first base-edited cell therapy for a patient with relapsed T cell leukemia

Researchers of the Hospital Universitario 12 de Octubre in Madrid and the Josep Carreras Leukaemia Research Institute have developed a cell therapy for a type of leukemia which currently has very few treatment options. The innovative STAb therapy has been developed thanks to funding from the Spanish Association Against Cancer (AECC). Researchers of the Hospital … Read more

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York have discovered that common cancer treatments, such as radiotherapy or anthracycline drugs, cause long-term damage to heart tissue by activating a key inflammatory signaling pathway. The study, published December 19 in the Journal of Experimental Medicine (JEM), suggests that inhibiting this pathway could reduce … Read more

Study shows positive effect of concentrating surgery for children with neuroblastoma

Study shows positive effect of concentrating surgery for children with neuroblastoma

Neuroblastoma is a tumor of the sympathetic nervous system that occurs mainly in young children. Every year, 25 children in the Netherlands receive this diagnosis. Surgery to remove the tumor tissue forms an important part of the treatment plan. Since November 2014, care for children in the Netherlands with a solid tumour, including neuroblastoma, has … Read more